These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35905252)

  • 1. Cardioprotective effect of Chinese herbal medicine for anthracycline-induced cardiotoxicity in cancer patients: A meta-analysis of prospective studies.
    Hao W; Shi YY; Qin YN; Sun CP; Chen LY; Wu CY; Bao YJ; Liu S
    Medicine (Baltimore); 2022 Jul; 101(30):e29691. PubMed ID: 35905252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy.
    van Dalen EC; van der Pal HJ; Kremer LC
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD005008. PubMed ID: 26938118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy.
    van Dalen EC; van der Pal HJ; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005008. PubMed ID: 17054232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective interventions for cancer patients receiving anthracyclines.
    van Dalen EC; Caron HN; Dickinson HO; Kremer LC
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003917. PubMed ID: 15674919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Traditional Chinese Medicine Injections for Anthracyclines-induced Cardiotoxicity: An Overview of Systematic Reviews and Meta-Analyses.
    Li C; Zheng Y; Niu D; Zhu R; Yan X; Qu H; Zhang Y
    Integr Cancer Ther; 2023; 22():15347354231164753. PubMed ID: 37057304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy.
    van Dalen EC; van der Pal HJ; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005008. PubMed ID: 19821337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different anthracycline derivates for reducing cardiotoxicity in cancer patients.
    van Dalen EC; Michiels EM; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2010 Mar; (3):CD005006. PubMed ID: 20238335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different anthracycline derivates for reducing cardiotoxicity in cancer patients.
    van Dalen EC; Michiels EM; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2010 May; 2010(5):CD005006. PubMed ID: 20464735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis.
    Caspani F; Tralongo AC; Campiotti L; Asteggiano R; Guasti L; Squizzato A
    Intern Emerg Med; 2021 Mar; 16(2):477-486. PubMed ID: 33011930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.
    Bryant J; Picot J; Levitt G; Sullivan I; Baxter L; Clegg A
    Health Technol Assess; 2007 Jul; 11(27):iii, ix-x, 1-84. PubMed ID: 17610809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different anthracycline derivates for reducing cardiotoxicity in cancer patients.
    van Dalen EC; Michiels EM; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005006. PubMed ID: 17054231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective interventions for cancer patients receiving anthracyclines.
    van Dalen EC; Caron HN; Dickinson HO; Kremer LC
    Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD003917. PubMed ID: 21678342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese herbal medicine for endometriosis.
    Flower A; Liu JP; Lewith G; Little P; Li Q
    Cochrane Database Syst Rev; 2012 May; (5):CD006568. PubMed ID: 22592712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective interventions for cancer patients receiving anthracyclines.
    van Dalen EC; Caron HN; Dickinson HO; Kremer LC
    Cochrane Database Syst Rev; 2008 Apr; (2):CD003917. PubMed ID: 18425895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal medicine for endometriosis.
    Flower A; Liu JP; Chen S; Lewith G; Little P
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006568. PubMed ID: 19588398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese herbal medicine for menopausal symptoms.
    Zhu X; Liew Y; Liu ZL
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009023. PubMed ID: 26976671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial.
    Hao W; Liu S; Qin Y; Sun C; Chen L; Wu C; Bao Y
    Trials; 2017 Aug; 18(1):386. PubMed ID: 28830541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.
    Li X; Xu S; Tan Y; Chen J
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010432. PubMed ID: 26037486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.